TERTp Mutation and its Prognostic Value in Glioma Patients Under the 2021 WHO Classification: A Real‐World Study

ABSTRACT Background The 2021 WHO Classification of Central Nervous System Tumors introduces more molecular markers for glioma reclassification, including TERT promoter (TERTp) mutation as a key feature in glioblastoma diagnosis. Aims Given the changes in the entities included in each subtype under t...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Hao Xing, Delin Liu, Junlin Li, Yulu Ge, Xiaopeng Guo, Wenlin Chen, Dachun Zhao, Yixin Shi, Yilin Li, Yaning Wang, Yuekun Wang, Yu Xia, Jiaming Wu, Tingyu Liang, Hai Wang, Qianshu Liu, Shanmu Jin, Tian Qu, Siying Guo, Huanzhang Li, Tianrui Yang, Kun Zhang, Yu Wang, Wenbin Ma
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2025-01-01
coleção:	Cancer Medicine
Assuntos:	adult‐type diffuse glioma glioma classification molecular subgroups prognosis TERT promoter mutation
Acesso em linha:	https://doi.org/10.1002/cam4.70533
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!